More than 25% of the U.S. popula- tion aged $65 years has diabetes (1), and the aging of the overall population is a significant driver of the diabetes epidemic. Although the burden of diabetes is often described in terms of its impact on working-age adults, diabetes inolderadultsislinkedtohighermortality, reduced functional status, and increased riskofinstitutionalization(2).Olderadults withdiabetesareatsubstantialriskforboth acute and chronic microvascular and car- diovascular complications of the disease. Despitehavingthehighestprevalenceof diabetes of any age-group, older persons and/or those with multiple comorbidities haveoftenbeenexcludedfromrandomized controlled trials of treatmentsdand treat- menttargetsdfordiabetesanditsassociated conditions.Heterogeneityofhealthstatusof older adults (even within an age range) and the dearth of evidence from clinical trials present challenges to determining standard intervention strategies that fit all older adults. To address these issues, the Ameri- can Diabetes Association (ADA) convened a Consensus Development Conference on Diabetes and Older Adults (defined as those aged $65 years) in February 2012. Following a series of scientific pre- sentations by experts in the field, the writing group independently developed